isopropyl-beta-galactopyranoside

Also Known As:

IPGP

Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thioglycosides: 17
    - Thiogalactosides: 1
      - Isopropyl Thiogalactoside: 62
        isopropyl-beta-galactopyranoside: 4
Carbohydrates: 22023
- Glycosides: 2119
  - Galactosides: 43
    - Thiogalactosides: 1
      - Isopropyl Thiogalactoside: 62
        isopropyl-beta-galactopyranoside: 4
  - Thioglycosides: 17
    - Thiogalactosides: 1
      - Isopropyl Thiogalactoside: 62
        isopropyl-beta-galactopyranoside: 4

Experts

1.	Abbas, Muhammad Nazim: 2 articles (08/2022 - 01/2019)
2.	Bright, Tim: 2 articles (08/2022 - 01/2019)
3.	Bull, Jeff: 2 articles (08/2022 - 01/2019)
4.	Gan, Susan: 2 articles (08/2022 - 01/2019)
5.	Karapetis, Christos Stelios: 2 articles (08/2022 - 01/2019)
6.	Roy, Amitesh Chandra: 2 articles (08/2022 - 01/2019)
7.	Vatandoust, Sina: 2 articles (08/2022 - 01/2019)
8.	Luu, Lee-Jen: 1 article (08/2022)
9.	Scott-Hoy, Alex: 1 article (08/2022)
10.	Sorich, Michael: 1 article (08/2022)

Related Diseases

1.	Stomach Neoplasms (Stomach Cancer) 08/01/2022 - "Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)." 01/01/2019 - "Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol."
2.	Neoplasm Metastasis (Metastasis) 08/01/2022 - "Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)." 01/01/2019 - "Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol."
3.	Gray Platelet Syndrome 01/01/2019 - "In an otherwise well child who presents abruptly with easy bruising and a platelet count >100×10/L, IPGP can be readily recognized as an acquired form of gray platelet syndrome. "
4.	Purpura 01/01/2019 - "The condition has been named idiopathic purpura with gray platelets (IPGP) or acquired platelet dysfunction with eosinophilia. "
5.	Insulin Resistance 05/01/2006 - "Eight procedures yielded satisfactory predictions of minimal model SI: (1) SI (from Matsuda's composite index)=-1.24+65/(IbGbImGm)-0.5; (2) SI=1.89+2690/(IbGbImGm); (3) SI (from Bennett's index)=-2.93+5.16/(log Ibxlog Gb); (4) SI (from Sluiter's index)=0.2+2400/(IpGp); (5) SI=-8.54+38.4/(Belfiore's ISI index); (6) SI (from Cederholm's formula)=76/(Gm log Im); (7) SI=0.248+0.947/GbIm; (8) SI (from Mari's "oral glucose insulin sensitivity" index)=oral glucose insulin sensitivity/Ip; (9) Caumo's model. "

Related Drugs and Biologics

1.	Paclitaxel (Taxol)
2.	Cisplatin (Platino)
3.	Capecitabine (Xeloda)
4.	Glucose (Dextrose)